Integration eines neuen Risikomarkers in die kardiovaskuläre Prävention: Beispiel Koronarkalk

Schlüsselwörter

kardiovaskuläre Prävention - Risikomarker - Koronarkalk

Keywords

cardiovascular prevention - risk marker - coronary artery calcium

Literatur

• 1 Becker A, Leber A, Becker C, Knez A. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals.  Am Heart J. 2008;  155 154-160
• 2 Brown E R, Kronmal R A, Bluemke D A. et al . Coronary calcium coverage score: determination, correlates, and predictive accuracy in the Multi-Ethnic Study of Atherosclerosis.  Radiology. 2008;  247 669-675
• 3 Budoff M J, Achenbach S, Blumenthal R S. et al . Assessment of CAD by Cardiac CT: A scientific statement from the AHA committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology.  Circulation. 2006;  114 1761-1791
• 4 Budoff M J, Shaw L J, Liu S T. et al . Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients.  JACC. 2007;  49 1860-1870
• 5 Chambless L, Keil U, Dobson A. et al, for the WHO MONICA Project . Population versus clinical view of case from acute coronary heart disease. Results from the WHO MONICA Project 1985 – 1990.  Circulation. 1997;  96 3849-3859
• 6 Detrano R, Guerci A D, Carr J J. et al . Coronary calcium as a predictor of coronary events in four racial or ethnic groups.  N Engl J Med. 2008;  358 1336-1345
• 7 Erbel R, Möhlenkamp S, Lehmann N. et al . Kardiovaskuläre Risikofaktoren und Zeichen subklinischer Atherosklerose – Daten der bevölkerungsbezogenen Heinz-Nixdorf-Recall-Studie.  Dtsch Ärztebl. 2008;  105 (1/2) 1-8
• 8 Erbel R, Möhlenkamp S, Lehmann N. et al, on behalf of the Heinz Nixdorf Recall Study Investigative Group . Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation.  Atherosclerosis. 2008;  197 (2) 662-72
• 9 Erbel R, Möhlenkamp S, Moebus S. et al .Signs of subclinical coronary atherosclerosis measured as coronary artery calcification improve risk prediction of hard events beyond traditional risk factors in an unselected general population: The Heinz Nixdorf Recall Study Five-Year Outcome Data. ACC Annual Meeting 2009. Late Breaking Clinical Trial. Presentation Number: 404 – 410. 
• 10 Erbel R. für die Heinz Nixdorf Recall Studiengruppe . Prädiktive Bedeutung der Koronarkalkbestimmung für kardiovaskuläre Ereignisse – Langzeitergebnisse der Heinz Nixdorf Recall Studie.  Clin Res Cardiol. 2009;  98 (Suppl1) V1490
• 11 Fox C S, Evans J C, Larson M G, Kannel W B, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study.  Circulation. 2004;  110 (5) 522-527
• 12 Greenland P, Bonow R O, Brundage B H. et al . ACCF/AHA 2007 clinical expert consensus document on CAC scoring by CT in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the ACC Foundation Clinical Expert Consensus Task Force.  Circulation. 2007;  115 402-426
• 13 Greenland P, LaBree L, Azen S P, Doherty T M, Detrano R C. CAC score combined with Framingham score for risk prediction in asymptomatic individuals.  JAMA. 2004;  291 210-215
• 14 Hense H W, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohorts.  Eur Heart J. 2003;  24 937-945
• 15 Hlatky M A, Greenland P, Arnett D K. et al, on behalf of the AHA expert panel on subclinical atherosclerotic diseases and emerging risk factors and the stroke council . Criteria for evaluation of novel markers of cardiovascular risk. A scientific statement from the American Heart Association.  Circulation. 2009;  119 2408-2416
• 16 Löwel H, Meisinger C, Heier M, Hörmann A, von Scheidt W. Herzinfarkt und koronare Sterblichkeit in Süddeutschland.  Dtsch Ärztebl. 2006;  103 (10) A 616-622
• 17 Melander O, Newton-Cheh C, Almgren P. et al . Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.  JAMA. 2009;  302 49-57
• 18 Oudkerk M, Stillman A E, Halliburton S S. et al . CAC screening: current status and recommendations from the European Society of Cardiac Radiology (ESCR) and North American Society for Cardiovascular Imaging (NASCI).  Eur Radiol. 2008;  18 (12) 2785-2807
• 19 Pencina M J, D’Agostino R B, D’Agostino R B Jr, Vasan R S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond.  Statist Med. 2008;  27 157-172
• 20 Raggi P, Shaw L J, Berman D S, Callister T Q. Prognostic value of CAC screening in subjects with and without diabetes.  J Am Coll Cardiol. 2004;  43 (9) 1663-1669
• 21 Redberg R F. Coronary artery calcium: should we rely on this surrogate marker?.  Circulation. 2006;  113 336-7
• 22 Rembold C M. Number needed to screen: development of a statistic for disease screening.  BMJ. 1998;  17 307-312
• 23 Ridker P M, Paynter N P, Rifai N, Gaziano J M, Cook N R. C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men.  Circulation. 2008;  118 2243-2251
• 24 Schmermund A, Möhlenkamp S, Berenbein S. et al . Population-based assessment of subclinical coronary atherosclerosis using EBCT.  Atherosclerosis. 2006;  185 (1) 177-182
• 25 Schmermund A, Möhlenkamp S, Stang A. et al for the Heinz Nixdorf Recall Study Investigative Group . Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf Recall study.  Am Heart J. 2002;  144 212-218
• 26 Shah T, Casas J P, Cooper J A. et al . Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.  Int J Epidemiol. 2009;  38 (1) 217-231
• 27 Simmons R K, Sharp S, Boekholdt S M, Sargeant L A, Khaw K T, Wareham N J, Griffin S J. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?.  Arch Intern Med. 2008;  168 (11) 1209-1216
• 28 Vergnaud A C, Bertraisa S, Galana P, Hercberga S, Czernichow S. Ten-year risk prediction in French men using the Framingham coronary score: Results from the national SU.VI.MAX cohort.  Prev Med. 2008;  47 (1) 61-65
• 29 Von Elm E, Altman D G, Egger M. et al STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies [published correction appears in Ann Intern Med 2008;148:168].  Ann Intern Med. 2007;  147 573-577
• 30 Zethelius B, Berglund L, Sundström J. et al . Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.  N Engl J Med. 2008;  358 2107-2116